Active Pharmaceutical Ingredient Market, By Type (Generic and Branded), By Business Mode (Captive API and Merchant API), By Synthesis Type (Synthetic and Biotech), By Application (Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology, and Orthopedic), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI68519 | Publish Date: March 2024 | No. of Pages: 187

Global Active Pharmaceutical Ingredient Market Overview

An active pharmaceutical ingredient (API) is a drug or mixture of drugs applicable in a finished pharmaceutical product (FPP). API is a biologically active ingredient within the drug product intended for the treatment, diagnosis, or prevention of a disease. It is the definite component liable for the desired effect it has on the subject using it. The Active pharmaceutical ingredients (API) market accounted for US$ 164.89 billion in 2020 and is estimated to be US$ 339.08 billion by 2030 and is anticipated to register a CAGR of 7.5%.

Global Active Pharmaceutical Ingredient Market Dynamics

Rising prevalence of infectious diseases

Rising prevalence of infectious diseases, cardiovascular conditions, and other chronic disorders among individuals globally is the major factor driving growth of the global market. In addition, due to rising prevalence of cancer, several manufacturers are focusing on development of highly potent APIs (HPAPI) and specialty APIs, thus boosting growth of the global market. According to data published by World health organization, cancer is the second leading cause of death globally and is projected to account for 9.6 million deaths in 2018.

Furthermore, large numbers of drugs are in the pipeline to develop treatments for cancer, autoimmune disorder, and metabolic diseases. Increasing healthcare expenditure and rising geriatric population in developing countries are expected to enhance growth of the target market over the forecast period. However, increasing penetration of counterfeit drugs and unfavorable drug price control policies across various countries is expected to hamper growth of the active pharmaceutical ingredients (API) market over the forecast period. Nevertheless, increasing demand toward the development of complex APIs used in novel formulations, targeting niche therapeutic areas is the major trend observed for the growth of the target market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Active Pharmaceutical Ingredient Market Segmentation

The active pharmaceutical ingredients (API) market is segmented based of type, business mode, synthetic type, application, and region.

Based on type, the active pharmaceutical ingredients (API) market is segmented into generic and branded. On the basis of business model, the global market is segmented into captive API and merchant API. On the basis of synthesis type, the global market is bifurcated into synthetic and biotech. Biotech synthesis type segment held the highest market share, owing to high demand for protein-based therapeutics and increasing focus of manufacturers toward biological drugs. Based on application, the target market is classified into Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology, and Orthopedic. Cardiology application segment accounts for the highest growth due to increasing prevalence rate and high amount of product availability.

Based on region the active pharmaceutical ingredients (API) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America is anticipated to dominate the global market, followed by Europe. Increasing government focus on generic drugs, coupled with growing incidence of preventable chronic diseases and rising demand for biologics and specialty drugs are the major factor driving growth of the global market in this region. In addition, technological advancements in the manufacturing processes of APIs also boost growth in this region. Asia pacific is projected to register the highest growth over the forecast period. Availability of affordable labor is the major reason industries are setting up the API manufacturing plants in the developing countries such as India and China.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Type- Generic and Branded

By Business Mode- Captive API and Merchant API

By Synthesis Type– Synthetic and Biotech

By Application- Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology, and Orthopedic

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study the active pharmaceutical ingredients (API) market is segmented based of type, business mode, synthetic type, application, and region.

Active Pharmaceutical Ingredient Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • U.S.
      • Canada

Global Active Pharmaceutical Ingredient Market Key Players

Key players operating in the active pharmaceutical ingredients (API) market includes Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG, Boehringer Ingelheim, GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., and Merck & Co., Inc. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global market. For instance, in January 2018, Sterling Pharma Solutions has expanded its presence in the Asia region, owing to increasing Japanese API market. The company aim to provide services such as hazardous chemistry, fluorination, and continuous processing as well as growth in emerging Pharma sector of Japan. In February 2018, ACETO Corporation partnership with Rising Pharmaceuticals and developed Atenolol tablets in range of 25mg, 50mg, and 100mg for hypertension.

Global Active Pharmaceutical Ingredient Market Company Profile

  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Bristol-Myers Squibb
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Boehringer Ingelheim
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance

Global Active Pharmaceutical Ingredient Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Business Mode
      • Market Snippet, By Synthesis Type
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  4. Market Segmentation, By Type, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Generic
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Branded
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  5. Market Segmentation, By Business Mode, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Captive API
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Merchant API
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  6. Market Segmentation, By Synthesis Type, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Synthetic
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Biotech
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  7. Market Segmentation, By Application, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Cardiology
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Pulmonology
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Oncology
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Ophthalmology
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Neurology
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Orthopedic
      • Overview
      • Market Business Mode and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  8. Global Market, By Region, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Business Mode, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Synthesis Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Business Mode, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Synthesis Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Business Mode, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Synthesis Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Business Mode, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Synthesis Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Business Mode, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Synthesis Type, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Business Mode and Forecast (US$ Bn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
    •  
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Sanofi SA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Bristol-Myers Squibb
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • AbbVie, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  11. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The active pharmaceutical ingredients (API) market is segmented based of type, business mode, synthetic type, application, and region.

Rising prevalence of infectious diseases, cardiovascular conditions, and other chronic disorders among individuals globally is the major factor driving growth of the global market.

Based on region the active pharmaceutical ingredients (API) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market, followed by Europe. Increasing government focus on generic drugs, coupled with growing incidence of preventable chronic diseases and rising demand for biologics and specialty drugs are the major factor driving growth of the global market in this region.

Key players operating in the active pharmaceutical ingredients (API) market includes Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG, Boehringer Ingelheim, GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., and Merck & Co., Inc.